It is unknown how the lack of insulin receptor (IR)/insulinlike growth factor I receptor (IGFIR) in a tissue-specific manner affects brown fat development and mitochondrial integrity and function, as well as its effect on the redistribution of the adipose organ and the metabolic status. To address this important issue, we developed IR/IGFIR double-knockout (DKO) in a brown adipose tissue-specific manner. Lack of those receptors caused severe brown fat atrophy, enhanced beige cell clusters in inguinal fat; loss of mitochondrial mass; mitochondrial damage related to cristae disruption; and the loss of proteins involved in autophagosome formation, mitophagy, mitochondrial quality control, and dynamics and thermogenesis. More important, DKO mice showed an impaired thermogenesis upon cold exposure, based on a failure in the mitochondrial fission mechanisms and a much lower uncoupling protein 1 transcription rate and content. As a result, DKO mice under normal conditions showed an obesity susceptibility, revealed by increased body fat mass and insulin resistance. Upon consumption of a high-fat diet, DKO mice displayed frank obesity, as shown by increased body weight, increased adiposity, insulin resistance, hyperinsulinemia, and hypertriglyceridemia, all consistent with a metabolic syndrome. Collectively, our data suggest a cause-and-effect relationship between failure in brown fat thermogenesis and increased adiposity and obesity.
Pubmed ID: 29040448 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets p62
View all literature mentionsThis polyclonal targets p62 Protein (C)
View all literature mentionsThis monoclonal targets alpha-Tubulin
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets OPA1
View all literature mentionsThis monoclonal targets DLP1
View all literature mentionsThis polyclonal targets Hadha
View all literature mentionsThis monoclonal targets TOMM20 antibody
View all literature mentionsThis polyclonal targets VDAC1
View all literature mentionsThis monoclonal targets Mfn2
View all literature mentionsThis polyclonal targets Parkin antibody
View all literature mentionsThis monoclonal targets BiP (C50B12) Rabbit mAb
View all literature mentionsThis polyclonal targets PPARGC1A
View all literature mentionsThis polyclonal targets LC3B
View all literature mentionsThis polyclonal targets Bcl-2
View all literature mentionsThis polyclonal targets Human DRP1, phospho (Ser616)
View all literature mentionsThis polyclonal targets UCP1
View all literature mentionsThis polyclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis polyclonal targets INSR
View all literature mentionsThis unknown targets Epitope maps to carboxy terminus of IGF-!R of human origin. Specific for IGF-IRbeta, Non-reactive with IGF-Iralpha
View all literature mentionsThis monoclonal targets alpha-Tubulin
View all literature mentionsThis polyclonal targets Hadha
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets OPA1
View all literature mentionsThis monoclonal targets DLP1
View all literature mentionsThis monoclonal targets BiP (C50B12) Rabbit mAb
View all literature mentionsThis polyclonal targets PPARGC1A
View all literature mentionsThis polyclonal targets LC3B
View all literature mentionsThis polyclonal targets Bcl-2
View all literature mentionsThis monoclonal targets TOMM20 antibody
View all literature mentionsThis polyclonal targets Human DRP1, phospho (Ser616)
View all literature mentionsThis polyclonal targets UCP1
View all literature mentionsThis polyclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis polyclonal targets VDAC1
View all literature mentionsThis polyclonal targets INSR
View all literature mentionsThis unknown targets Epitope maps to carboxy terminus of IGF-!R of human origin. Specific for IGF-IRbeta, Non-reactive with IGF-Iralpha
View all literature mentionsThis monoclonal targets Mfn2
View all literature mentionsThis polyclonal targets Parkin antibody
View all literature mentionsThis polyclonal targets p62
View all literature mentions